CluePoints, a Louvain-La-Neuve, Belgium-based supplier of a cloud-based software program platform for Threat-Based mostly High quality Administration (“RBQM”) and knowledge high quality oversight in scientific trials, obtained a majority funding from EQT.
The quantity of the deal was not disclosed. The transaction is topic to customary situations and approvals. It’s anticipated to shut in Q3 2024. Summit Companions, an investor in CluePoints since 2020, and Clinimetrics SA, a co-founder of CluePoints, will retain minority stakes with participation on this funding spherical.
The corporate intends to make use of the funds to increase operations and its enterprise attain.
Led by CEO Andy Cooper, CluePoints is a premier software program supplier for RBQM and knowledge high quality oversight in scientific trials. Making use of superior statistics and machine studying, and harnessing over 10 years of scientific trials information, CluePoints’ proprietary algorithms assist drive optimistic outcomes for pharmaceutical and biotech firms, contract analysis organizations and different clients. The corporate gives an end-to-end worth proposition from preliminary danger identification to ongoing monitoring and monitoring of points and discrepancies all through the drug growth course of. With greater than 9,500 platform customers, CluePoints has helped de-risk greater than 1,600 research and has detected over 142,000 points for its clients, which embody lots of the high 20 largest pharma firms.
FinSMEs
12/06/2024
